Snap Shot A 77-year-old man is brought in by EMS after waking up in the middle of the night covered in sweat, with a high fever, and a coughing up yellow sputum. A chest xray is shown. Introduction Definition infection of lung parenchyma that usually occurs in defined lobar patterns, though may also present more diffusely Clinically defined as fever, cough and new infiltrate on CXR Pathophysiology See Microbiology of Pneumonia topic Risk factors impaired cough reflex damage to respiratory cilia mucus plugs Classification Classic patterns include lobar intra-alveolar exudate which consolidates may involve entire lung or be confined to 1 lobe 4 stages brochopnuemonia acute inflammatory infiltrates from bronchioles into adjacent alveoli patchy distribution involves ≥ 1 lobes interstitial diffuse patchy inflammation localized to interstitial areas of alveolar walls distribution involving ≥ 1 lobes generally less severe than lobar or bronchopneumonia Presentation Symptoms classically presents with sudden-onset of fever productive cough purulent yellow-green hemoptysis dyspnea night sweats pleuritic chest pain atypical presentations are gradual in onset and flu-like dry cough headaches myalgias sore throat Physical exam auscultation of the lungs reveals decreased or bronchial breath sounds crackles/rales wheezing E-to-A egophany with consolidation percussion reveals dullness over affected lobe(s) tactile fremitus increased with consolidation decreased with pleural effusion Evaluation CXR may show lung opacification/consolidation in affected lobe(s) establishes diagnosis in combination with Gram stain or culture CBC elevated WBC count Sputum Gram stain and cultures identify pathogen directs antimicrobial therapy Treatment Pharmacologic empiric antibiotics directed at most likely pathogens (depends on clinical scenario) organism-specific antibiotics if organism identified
QUESTIONS 1 of 4 1 2 3 4 Previous Next Lab Values Blood Hematologic Cerebrospinal Sweat, Urine, and BMI Blood, Plasma, Serum Reference Range ALT 8-20 U/L Amylase, serum 25-125 U/L AST 8-20 U/L Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL Calcium, serum (Ca2+) 8.4-10.2 mg/dL Cholesterol, serum Rec: < 200 mg/dL Cortisol, serum 0800 h: 5-23 μg/dL //1600 h: 3-15 μg/dL 2000 h: ≤ 50% of 0800 h Creatine kinase, serum Male: 25-90 U/LFemale: 10-70 U/L Creatinine, serum 0.6-1.2 mg/dL Electrolytes, serum Sodium (Na+) 136-145 mEq/L Chloride (Cl-) 95-105 mEq/L Potassium (K+) 3.5-5.0 mEq/L Bicarbonate (HCO3-) 22-28 mEq/L Magnesium (Mg2+) 1.5-2.0 mEq/L Estriol, total, serum (in pregnancy) 24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL 28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL Ferritin, serum Male: 15-200 ng/mLFemale: 12-150 ng/mL Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL Female: premenopause: 4-30 mIU/mL midcycle peak: 10-90 mIU/mL postmenopause: 40-250 pH 7.35-7.45 PCO2 33-45 mmHg PO2 75-105 mmHg Glucose, serum Fasting: 70-110 mg/dL2-h postprandial:<120 mg/dL Growth hormone - arginine stimulation Fasting: <5 ng/mLProvocative stimuli: > 7ng/mL Immunoglobulins, serum IgA 76-390 mg/dL IgE 0-380 IU/mL IgG 650-1500 mg/dL IgM 40-345 mg/dL Iron 50-170 μg/dL Lactate dehydrogenase, serum 45-90 U/L Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL Female: follicular phase: 5-30 mIU/mL midcycle: 75-150 mIU/mL postmenopause 30-200 mIU/mL Osmolality, serum 275-295 mOsmol/kd H2O Parathyroid hormone, serume, N-terminal 230-630 pg/mL Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L Phosphorus (inorganic), serum 3.0-4.5 mg/dL Prolactin, serum (hPRL) < 20 ng/mL Proteins, serum Total (recumbent) 6.0-7.8 g/dL Albumin 3.5-5.5 g/dL Globulin 2.3-3.5 g/dL Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h Thyroxine (T4), serum 5-12 μg/dL Triglycerides, serum 35-160 mg/dL Triiodothyronine (T3), serum (RIA) 115-190 ng/dL Triiodothyronine (T3) resin uptake 25%-35% Urea nitrogen, serum 7-18 mg/dL Uric acid, serum 3.0-8.2 mg/dL Hematologic Reference Range Bleeding time 2-7 minutes Erythrocyte count Male: 4.3-5.9 million/mm3Female: 3.5-5.5 million mm3 Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/hFemale: 0-20 mm/h Hematocrit Male: 41%-53%Female: 36%-46% Hemoglobin A1c ≤ 6 % Hemoglobin, blood Male: 13.5-17.5 g/dLFemale: 12.0-16.0 g/dL Hemoglobin, plasma 1-4 mg/dL Leukocyte count and differential Leukocyte count 4,500-11,000/mm3 Segmented neutrophils 54%-62% Bands 3%-5% Eosinophils 1%-3% Basophils 0%-0.75% Lymphocytes 25%-33% Monocytes 3%-7% Mean corpuscular hemoglobin 25.4-34.6 pg/cell Mean corpuscular hemoglobin concentration 31%-36% Hb/cell Mean corpuscular volume 80-100 μm3 Partial thromboplastin time (activated) 25-40 seconds Platelet count 150,000-400,000/mm3 Prothrombin time 11-15 seconds Reticulocyte count 0.5%-1.5% of red cells Thrombin time < 2 seconds deviation from control Volume Plasma Male: 25-43 mL/kgFemale: 28-45 mL/kg Red cell Male: 20-36 mL/kgFemale: 19-31 mL/kg Cerebrospinal Fluid Reference Range Cell count 0-5/mm3 Chloride 118-132 mEq/L Gamma globulin 3%-12% total proteins Glucose 40-70 mg/dL Pressure 70-180 mm H2O Proteins, total < 40 mg/dL Sweat Reference Range Chloride 0-35 mmol/L Urine Calcium 100-300 mg/24 h Chloride Varies with intake Creatinine clearance Male: 97-137 mL/minFemale: 88-128 mL/min Estriol, total (in pregnancy) 30 wks 6-18 mg/24 h 35 wks 9-28 mg/24 h 40 wks 13-42 mg/24 h 17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 hFemale: 2.0-8.0 mg/24 h 17-Ketosteroids, total Male: 8-20 mg/24 hFemale: 6-15 mg/24 h Osmolality 50-1400 mOsmol/kg H2O Oxalate 8-40 μg/mL Potassium Varies with diet Proteins, total < 150 mg/24 h Sodium Varies with diet Uric acid Varies with diet Body Mass Index (BMI) Adult: 19-25 kg/m2 Calculator ( ) xy AC 7 8 9 ÷ 4 5 6 × 1 2 3 - 0 . = + Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK (M1.PL.24) Myeloperoxidase (MPO) is a heme-containing molecule that is found in the azurophilic granules of neutrophils. Upon release, the enzyme catalyzes hypochlorous acid production during the phagocytic response. In the setting of pneumonia, which of the following is the end result and clinical significance of this reaction? Review Topic QID: 100827 1 Green color of sputum 60% (3/5) 2 Cough 0% (0/5) 3 Rust-tinged sputum 40% (2/5) 4 Fever 0% (0/5) 5 Shortness of breath 0% (0/5) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 1 (M1.PL.37) A 21-year-old college student with a history of hypertrophic cardiomyopathy and a systolic murmur heard best at the left sternal border presents to the emergency room with a temperature of 102.3 F, worsening shortness of breath, chest pain and productive cough. He states that two days ago upon returning from Spring Break in Australia he drank a significant amount of alcohol and had an episode of vomiting. He recalls little about the evening. His electrocardiogram displays a regular sinus rhythm and his chest x-ray is shown in Figure A. Which of the following is the most likely etiology of his illness? Review Topic QID: 100102 FIGURES: A 1 Long-distance travel 7% (1/15) 2 Impaired cough reflex 40% (6/15) 3 Hypertrophic cardiomyopathy 20% (3/15) 4 Valvular disease 13% (2/15) 5 Close living quarters 20% (3/15) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 2 (M1.PL.136) A 48-year-old male dies in the intensive care unit following a severe Streptococcus pneumonia pneumonia and septic shock. Autopsy of the lung reveals a red, firm left lower lobe. What would you most likely find on microscopic examination of the lung specimen? Review Topic QID: 100939 1 Eosinophilia in the alveolar septa 6% (5/87) 2 Vascular dilation and noncaseating granulomas 7% (6/87) 3 Fragmented erythrocytes 9% (8/87) 4 Alveolar exudate containing neutrophils, erythrocytes, and fibrin 71% (62/87) 5 Collagen whorls 2% (2/87) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 4
pdf Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Respiratory - Humanitarian Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT Thorax. 2003 May;58(5):377-82. PMID: 12728155 (Link to Abstract)
Login to View Community Videos Login to View Community Videos Egophony Thomas Heineman Respiratory - Pneumonia 3/2/2015 31 views Login to View Community Videos Login to View Community Videos Pneumonia Chris Battista Respiratory - Pneumonia 3/27/2013 33 views